Vaginal News and Research

RSS

Study suggests possibility of engineering artificial ovaries in lab

A proof-of-concept study suggests the possibility of engineering artificial ovaries in the lab to provide a more natural option for hormone replacement therapy for women.

27 Mar 2013

Certain strains of lactobacillus bacteria can dampen production of toxic shock syndrome toxin 1

Certain Streptococci increase their production of toxic shock syndrome toxin 1, sometimes to potentially dangerous levels, when aerobic bacteria are present in the vagina. But scientists from the University of Western Ontario have discovered certain strains of lactobacillus bacteria are capable of dampening production of that toxin according to research published in the journal Applied and Environmental Microbiology.

25 Mar 2013

HIV home tests: an interview with Dr Nitika Pant Pai, McGill University

30 years into the HIV epidemic, there is no vaccine in sight. Yet, even though there are fantastic and effective cheap and universally available drugs, and a treatment as prevention strategy is known to work, people do not wish to get tested for HIV! If everyone got tested, and treated, we could have brought the infection under control a long time ago!

21 Mar 2013

Independent maternal demographic factors can predict likelihood of operative births in UK: Study

Independent maternal demographic factors such as social status, ethnicity and maternal age can predict the likelihood of operative births in the UK, according to a new study published today (20 March) in BJOG: An International Journal of Obstetrics and Gynaecology.

21 Mar 2013

Study evaluates mesh-related complications for surgical management of female POP

Younger age, less prominent prolapse and concomitant hysterectomies are associated with a higher risk of peri-operative and mesh-related complications after prolapse repair with trocar-guided transvaginal mesh, according to a study presented by a Russian group at the 28th Annual EAU Congress.

21 Mar 2013

Hepatitis C virus rarely transmitted through sex between monogamous heterosexuals

Individuals infected by the hepatitis C virus (HCV) have nothing to fear from sex in a monogamous, heterosexual relationship. Transmission of HCV from an infected partner during sex is rare according to new research published in the March issue of Hepatology, a journal published by Wiley on behalf of the American Association for the Study of Liver Diseases (AASLD).

19 Mar 2013

Survey shows active women are more likely to prefer midwifery care and planned home birth

Women who see themselves as active participants in the delivery of their first child, and prefer a collaborative role with their healthcare provider are more likely to prefer planned home birth and the care of a midwife, according to a new survey conducted by Columbia University School of Nursing's Adriana Arcia, PhD, RN, and published in the journal Midwifery.

15 Mar 2013

Completion rates for HPV vaccine series continue to remain low, say UTMB researchers

Completion rates for the human papillomavirus (HPV) vaccine series across both genders continue to remain alarmingly low nearly seven years after its introduction, suggesting that better patient education and increased public vaccine financing programs are needed, according to new research from the University of Texas Medical Branch (UTMB).

15 Mar 2013

Listen to women's needs when designing HIV prevention strategies

According to "results from a large HIV prevention trial among African women" known as VOICE and released last week, "none of the prevention methods tested in the study made a difference in HIV infection rates, because few women actually used them as directed," AVAC Executive Director Mitchell Warren writes in an opinion piece published in the Huffington Post's "Global Motherhood" blog.

12 Mar 2013

Einstein researchers to develop drug-impregnated intravaginal ring for HIV prevention in women

Researchers at Albert Einstein College of Medicine of Yeshiva University have been awarded a $12 million grant from the National Institutes of Health (NIH) to develop a drug-impregnated intravaginal ring to prevent HIV infection in women.

11 Mar 2013

Melittin-loaded nanoparticles can destroy human immunodeficiency virus

Nanoparticles carrying a toxin found in bee venom can destroy human immunodeficiency virus (HIV) while leaving surrounding cells unharmed, researchers at Washington University School of Medicine in St. Louis have shown.

8 Mar 2013

Across the nation, C-section rates show wide variation

C-sections, a very common operating room procedure, can boost the cost of delivery from about $9,000 for a vaginal birth to $13,000.

6 Mar 2013

Study: Hospital cesarean rates vary widely across U.S. hospitals

Cesarean delivery is the most common surgery in the United States, performed on 1.67 million American women annually. Yet hospital cesarean rates vary widely according to new research from the University of Minnesota's School of Public Health.

6 Mar 2013

Women's low adherence to daily-dose products in HIV prevention trial suggest different approach needed, researchers say

"Results of a major HIV prevention trial suggest that daily use of a product -- whether a vaginal gel or an oral tablet -- does not appear to be the right approach for preventing HIV in young, unmarried African women," a press release from the Microbicide Trials Network reports.

6 Mar 2013

SGO's 44th Annual Meeting on Women's Cancer to be held in Los Angeles

Ovarian cancer treatment, health care reform, the impact of obesity on gynecologic health and the delivery of high quality gynecologic cancer care highlight the Society of Gynecologic Oncology's (SGO) 44th Annual Meeting on Women's Cancer March 9-12 in Los Angeles.

6 Mar 2013

Forceps delivery ‘does not increase atopy risk’

Results from a population-based cohort study suggest that forceps-assisted birth is associated with an increased risk for asthma, but not allergic sensitization, in later childhood.

5 Mar 2013

Study finds antiretroviral-based strategies to prevent HIV infection among women prove ineffective

Three antiretroviral-based strategies intended to prevent HIV infection among women did not prove effective in a major clinical trial in Africa.

5 Mar 2013

WomanCare Global, Evofem enter strategic alliance

Evofem announced today that it has entered into a strategic alliance with WomanCare Global. Through this alliance, WomanCare Global will provide sales, marketing and global distribution for a selection of Evofem's products, including Softcup and Amphora.

4 Mar 2013

Macrophages allow entry of HIV in the urethra

Having suggested in 2011 that the urethra is a novel entry site for HIV, a team from the Institut Cochin, has now confirmed this hypothesis and identified the cells and mechanisms brought into play: the immune system cells macrophages, present in the epithelium of the urethra, allow the entry of HIV. This work, published online on the website of the journal Mucosal Immunology, could make it possible to test novel HIV/AIDS prevention strategies.

1 Mar 2013

Shionogi receives FDA approval for Osphena to treat women with severe dyspareunia

The U.S. Food and Drug Administration today approved Osphena (ospemifene) to treat women experiencing moderate to severe dyspareunia (pain during sexual intercourse), a symptom of vulvar and vaginal atrophy due to menopause.

26 Feb 2013

Vaginal News and Research

Study suggests possibility of engineering artificial ovaries in lab

Certain strains of lactobacillus bacteria can dampen production of toxic shock syndrome toxin 1

HIV home tests: an interview with Dr Nitika Pant Pai, McGill University

Independent maternal demographic factors can predict likelihood of operative births in UK: Study

Study evaluates mesh-related complications for surgical management of female POP

Hepatitis C virus rarely transmitted through sex between monogamous heterosexuals

Survey shows active women are more likely to prefer midwifery care and planned home birth

Completion rates for HPV vaccine series continue to remain low, say UTMB researchers

Listen to women's needs when designing HIV prevention strategies

Einstein researchers to develop drug-impregnated intravaginal ring for HIV prevention in women

Melittin-loaded nanoparticles can destroy human immunodeficiency virus

Across the nation, C-section rates show wide variation

Study: Hospital cesarean rates vary widely across U.S. hospitals

Women's low adherence to daily-dose products in HIV prevention trial suggest different approach needed, researchers say

SGO's 44th Annual Meeting on Women's Cancer to be held in Los Angeles

Forceps delivery ‘does not increase atopy risk’

Study finds antiretroviral-based strategies to prevent HIV infection among women prove ineffective

WomanCare Global, Evofem enter strategic alliance

Macrophages allow entry of HIV in the urethra

Shionogi receives FDA approval for Osphena to treat women with severe dyspareunia

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News